Because Dagmar needs to find a way to cover up all of her failed decisions. She will always win no matter what....ask Randi.
Successful? You probably think Gilenya is successful because Leaderships tells you it is a billion dollar product. The truth - It is a failure. Failure to live up to its potential. Failure to achieve a respectable market share. Failure in Novartis to establish respect in the MS space. Leadership realizes the failure of Gilenya but they are required to spin the information to keep us motivated. If leadership cannot justify paying reps there will be layoffs. 2 reps in a territory is over.
I'm still not sure how cutting rep numbers makes any sense. the product doesn't sell itself. Too much doubt about safety due to lack of understanding which holds back sales, too many competitors with active sales teams ready to take advantage of a situation that suddenly tilts in their favor, too much dependence on the revenue from G for NPC. it doesn't matter that the product failed to live up to its potential, what matters is that it still can contribute substantially to the bottom line, even if all it does is continue at current pace or with minimal growth.
Don't listen to these morons about layoffs. The drug is doing 1.3 billion a year its a blockbuster. Is it a failure on what the true potential should of been yes! How many other Novartis drugs do 1.3 billion they need us.
